| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 7-香叶草氧基-5-甲氧基香豆素; 7-Geranyloxy-5-methoxycoumarin | CFN99003 | 1432075-68-7 | C20H24O4 = 328.4 | 5mg | QQ客服：1457312923 |
| 异橙皮内酯 ; Isomeranzin | CFN99090 | 1088-17-1 | C15H16O4 = 260.3 | 20mg | QQ客服：2159513211 |
| 九里香醇; Murraol | CFN99097 | 109741-38-0 | C15H16O4 = 260.3 | 5mg | QQ客服：215959384 |
| 滨蒿內酯; Scoparone | CFN99314 | 120-08-1 | C11H10O4 = 206.2 | 20mg | QQ客服：1457312923 |
| Moluccanin; Moluccanin | CFN99333 | 121700-26-3 | C20H18O8 = 386.4 | 5mg | QQ客服：3257982914 |
| Moluccanin diacetate; Moluccanin diacetate | CFN99334 | 121700-27-4 | C24H22O10 = 470.4 | 5mg | QQ客服：1457312923 |
| 酸橙素烯醇; Auraptenol | CFN99340 | 1221-43-8 | C15H16O4 = 260.3 | 5mg | QQ客服：3257982914 |
| 8-香叶基氧基-5,7-二甲氧基香豆素; 8-Geranyloxy-5,7-dimethoxycoumarin | CFN99344 | 1228175-65-2 | C21H26O5 = 358.4 | 5mg | QQ客服：1413575084 |
| (S)-8-(3-乙氧基-2-羟基-3-甲基丁基)-7-甲氧基-2H-1-苯并吡喃-2-酮; 8-(3-Ethoxy-2-hydroxy-3-methylbutyl)-7-methoxycoumarin | CFN99362 | 125072-68-6 | C17H22O5 = 306.4 | 5mg | QQ客服：2056216494 |
| 异欧前胡素; Isoimperatorin | CFN99107 | 482-45-1 | C16H14O4 = 270.28 | 20mg | QQ客服：1413575084 |
| 茴芹内酯; Pimpinellin | CFN99402 | 131-12-4 | C13H10O5 = 246.2 | 20mg | QQ客服：2159513211 |
| 秦皮素; Fraxetin | CFN99113 | 574-84-5 | C10H8O5 = 208.17 | 20mg | QQ客服：1457312923 |
| 秦皮甲素; Esculin | CFN99114 | 531-75-9 | C15H16O9 = 340.28 | 20mg | QQ客服：215959384 |
| 6,7-二羟基香豆素; 6,7-Dihydroxycoumarin | CFN99115 | 305-01-1 | C9H6O4 = 178.14 | 20mg | QQ客服：215959384 |
| 飞龙拳血新双香豆精; Toddalosin | CFN99429 | 137182-37-7 | C32H34O9 = 562.6 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)